The Journal of Phytopharmacology 2024; 13(4):286-293 ; DOI:10.31254/phyto.2024.13403
Addressing the Global Challenge: Strategies for Cervical Prevention and Early Detection within WHO's 90-70-90 Framework
Mohd Mustafa1 , Misba Naim2 , Mudassir Alam3 , Kashif Abbas3 , Waleem Ahmad4 , Neda Tufail5 , Irfan Qadir Tantry6 , Sidra Islam7 , Hamda Khan5 , Rizwan Ahmad5 , Nazura Usmani3 , Moinuddin5 , Safia Habib1
1. Department of Biochemistry, Jawaharlal Nehru Medical College, Faculty of Medicine, Aligarh Muslim University, Aligarh, India
2. Department of Obstetrics and Gynaecology, Glocal Unani Medical College, Glocal University, India
3. Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India
4. Department of Medicine, J.N. Medical College, Aligarh Muslim University, Aligarh, India
5. Department of Biochemistry, J.N. Medical College, Aligarh Muslim University, Aligarh, India
6. Department of Biochemistry, School of Biological Sciences, University of Kashmir, Srinagar, India
7. Department of Inflammation & Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, USA
*Author to whom correspondence should be addressed.
Received: 14th May, 2024 / Accepted: 29th July, 2024 / Published : 31st August, 2024
Cervical cancer represents a substantial global health issue, standing as the third most prevalent cancer globally and the principal cause of cancer-associated mortality in women, with an uneven burden shouldered by less developed countries. Despite being the most preventable malignancy, with nearly all cases attributed to HPV infection, which has a lifetime cumulative risk of 80% through sexual transmission, cervical cancer remains a pressing issue. National cervical cytology screening programs have been implemented to identify cervical abnormalities, lesions, and early malignancies in eligible women. However, the utilization of screening techniques is declining, and due to resource constraints, screening schemes have not been adopted in less-developed economies. Several nations have embraced alternative screening techniques, such as Visual Inspection with Acetic Acid (VIA), which have shown impacts on mortality and morbidity rates. With the rising accessibility of efficacious HPV screening and self-testing, there will be a necessity to reconfigure existing cervical screening programs. Furthermore, preventative HPV vaccination is an integral part of the World Health Organization’s (WHO) Global Strategy to Expedite the Eradication of Cervical Cancer as a Public Health Issue, necessitating the restructuring of vaccination endeavors. This review article evaluates potential techniques for detecting precancerous lesions within the context of the WHO's 90-70-90 global policy for cervical cancer prevention and early diagnosis. The incidence and mortality rates are examined, highlighting the effectiveness of cervical cancer prevention efforts.
Cervical Cancer, Prevention Strategies, Global Health Challenge, HPV Vaccination, Cervical Cancer Screening, WHO 90-70-90 Strategy
HOW TO CITE THIS ARTICLE
Mustafa M, Naim M, Alam M, Abbas K, Ahmad W, Tufail N, Tantry IQ, Islam S, Khan H, Ahmad R, Usmani N, Moinuddin, Habib S. Addressing the Global Challenge: Strategies for Cervical Prevention and Early Detection within WHO's 90-70-90 Framework. J Phytopharmacol 2024; 13(4):286-293. doi: 10.31254/phyto.2024.13403
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.